Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care
Luca Quartuccio, Arianna Sonaglia, Dennis McGonagle, Martina Fabris, Maddalena Peghin, Davide Pecori, Amato De Monte, Tiziana Bove, Francesco Curcio, Flavio Bassi, Salvatore De Vita, Carlo Tascini
Topics & Concepts
MedicineTocilizumabCytokine stormSuperinfectionPneumoniaInternal medicineInterleukin 6Case fatality rateRetrospective cohort studyViral pneumoniaCytokineOdds ratioGastroenterologyCoronavirus disease 2019 (COVID-19)ImmunologyDiseaseEpidemiologyVirusInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research